Related Experiment Video
Updated: Apr 29, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Toll-like receptor 4 mutant and null mice retain morphine-induced tolerance, hyperalgesia, and physical dependence
Theresa Alexandra Mattioli1, Heather Leduc-Pessah2, Graham Skelhorne-Gross3
1Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Abstract:
The innate immune system modulates opioid-induced effects within the central nervous system and one target that has received considerable attention is the toll-like receptor 4 (TLR4). Here, we examined the contribution of TLR4 in the development of morphine tolerance, hyperalgesia, and physical dependence in two inbred mouse strains: C3H/HeJ mice which have a dominant negative point mutation in the Tlr4 gene rendering the receptor non-functional, and B10ScNJ mice which are TLR4 null mutants. We found that neither acute antinociceptive response to a single dose of morphine, nor the development of analgesic tolerance to repeated morphine treatment, was affected by TLR4 genotype. Likewise, opioid induced hyperalgesia and opioid physical dependence (assessed by naloxone precipitated withdrawal) were not altered in TLR4 mutant or null mice. We also examined the behavioural consequence of two stereoisomers of naloxone: (-) naloxone, an opioid receptor antagonist, and (+) naloxone, a purported antagonist of TLR4. Both stereoisomers of naloxone suppressed opioid induced hyperalgesia in wild-type control, TLR4 mutant, and TLR4 null mice. Collectively, our data suggest that TLR4 is not required for opioid-induced analgesic tolerance, hyperalgesia, or physical dependence.
Insights
Toll-like receptor 4 (TLR4) does not influence morphine tolerance, hyperalgesia, or physical dependence. Studies in TLR4 mutant and null mice show no impact on opioid-induced effects, suggesting TLR4 is not essential for these responses.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- The innate immune system, particularly toll-like receptor 4 (TLR4), plays a role in modulating central nervous system responses to opioids.
- Understanding TLR4's contribution to opioid-induced effects is crucial for managing pain and addiction.
Purpose of the Study:
- To investigate the role of toll-like receptor 4 (TLR4) in the development of morphine tolerance, hyperalgesia, and physical dependence.
- To compare these effects in mice with non-functional or absent TLR4.
Main Methods:
- Utilized two inbred mouse strains: C3H/HeJ (dominant negative Tlr4 mutation) and B10ScNJ (TLR4 null mutants).
- Assessed acute antinociception, analgesic tolerance, opioid-induced hyperalgesia, and physical dependence (naloxone-precipitated withdrawal).
- Examined the effects of (-) naloxone and (+) naloxone stereoisomers on opioid-induced hyperalgesia.
Main Results:
- TLR4 genotype did not affect acute antinociceptive responses to morphine.
- The development of analgesic tolerance to repeated morphine treatment was independent of TLR4 status.
- Opioid-induced hyperalgesia and physical dependence were not altered in TLR4 mutant or null mice.
- Both naloxone stereoisomers suppressed opioid-induced hyperalgesia in all mouse strains tested.
Conclusions:
- Toll-like receptor 4 (TLR4) is not required for the development of morphine tolerance.
- TLR4 does not play a significant role in opioid-induced hyperalgesia or physical dependence.
- These findings suggest that TLR4 is not a critical mediator of common opioid-induced adverse effects.
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Drug Abuse and Addiction: Pharmacological Phenomena

